KIORA PHARMACEUTICALS, INC. Interest Expense
KIORA PHARMACEUTICALS, INC. (KPRX) reported Interest Expense of $11.13 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-25.
Discontinued › Expense Statement
us-gaap:InterestExpense · last filed 2024-03-25
- KIORA PHARMACEUTICALS, INC. interest expense for the quarter ending 2021-12-31 was $4.13K, a 1.29% decline year-over-year.
- KIORA PHARMACEUTICALS, INC. interest expense for the quarter ending 2021-09-30 was $0.00.
- KIORA PHARMACEUTICALS, INC. interest expense for the quarter ending 2021-06-30 was $2.03K.
- KIORA PHARMACEUTICALS, INC. interest expense for the quarter ending 2021-03-31 was $686.00.
- KIORA PHARMACEUTICALS, INC. interest expense for fiscal 2023 was $11.13K, a 29.46% increase from fiscal 2022.
- KIORA PHARMACEUTICALS, INC. interest expense for fiscal 2022 was $8.60K, a 25.51% increase from fiscal 2021.
- KIORA PHARMACEUTICALS, INC. interest expense for fiscal 2021 was $6.85K, a 63.66% increase from fiscal 2020.
- KIORA PHARMACEUTICALS, INC. interest expense for fiscal 2020 was $4.19K, a 1188.00% increase from fiscal 2019.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2023-12-31 | $11.13K 10-K · filed 2024-03-25 | |||
| 2022-12-31 | $8.60K 10-K · filed 2024-03-25 | |||
| 2021-12-31 | $4.13K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $4.13K derived: sum of 2 quarters · filed 2023-03-23 | $6.17K derived: sum of 3 quarters · filed 2023-03-23 | $6.85K 10-K · filed 2023-03-23 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $2.03K derived: sum of 2 quarters · filed 2022-08-12 | $2.72K 10-Q · filed 2021-11-15 | $6.91K derived: sum of 4 quarters · filed 2022-08-12 |
| 2021-06-30 | $2.03K 10-Q · filed 2022-08-12 | $2.72K 10-Q · filed 2022-08-12 | $6.91K derived: sum of 3 quarters · filed 2022-08-12 | $6.91K derived: sum of 4 quarters · filed 2022-08-12 |
| 2021-03-31 | $686.00 10-Q · filed 2022-07-08 | $4.87K derived: sum of 2 quarters · filed 2022-07-08 | $4.87K derived: sum of 3 quarters · filed 2022-07-08 | $4.87K derived: sum of 4 quarters · filed 2022-07-08 |
| 2020-12-31 | $4.19K derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-07-07 | $4.19K derived: sum of 2 quarters · filed 2022-07-07 | $4.19K derived: sum of 3 quarters · filed 2022-07-07 | $4.19K 10-K/A · filed 2022-07-07 |
| 2020-09-30 | $0.00 10-Q · filed 2020-11-09 | $0.00 derived: sum of 2 quarters · filed 2020-11-09 | $0.00 10-Q · filed 2020-11-09 | $0.00 derived: sum of 4 quarters · filed 2021-03-25 |
| 2020-06-30 | $0.00 10-Q · filed 2020-08-06 | $0.00 10-Q · filed 2020-08-06 | $0.00 derived: sum of 3 quarters · filed 2021-03-25 | $109.00 derived: sum of 4 quarters · filed 2021-03-25 |
| 2020-03-31 | $0.00 10-Q · filed 2020-05-06 | $0.00 derived: sum of 2 quarters · filed 2021-03-25 | $109.00 derived: sum of 3 quarters · filed 2021-03-25 | $217.00 derived: sum of 4 quarters · filed 2021-03-25 |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $109.00 derived: sum of 2 quarters · filed 2021-03-25 | $217.00 derived: sum of 3 quarters · filed 2021-03-25 | $325.00 10-K · filed 2021-03-25 |
| 2019-09-30 | $109.00 10-Q · filed 2020-11-09 | $217.00 derived: sum of 2 quarters · filed 2020-11-09 | $325.00 10-Q · filed 2020-11-09 | $453.00 derived: sum of 4 quarters · filed 2020-11-09 |
| 2019-06-30 | $108.00 10-Q · filed 2020-08-06 | $216.00 10-Q · filed 2020-08-06 | $344.00 derived: sum of 3 quarters · filed 2020-08-06 | $648.00 derived: sum of 4 quarters · filed 2020-08-06 |
| 2019-03-31 | $108.00 10-Q · filed 2020-05-06 | $236.00 derived: sum of 2 quarters · filed 2020-05-06 | $540.00 derived: sum of 3 quarters · filed 2020-05-06 | $844.00 derived: sum of 4 quarters · filed 2020-05-06 |
| 2018-12-31 | $128.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-04 | $432.00 derived: sum of 2 quarters · filed 2020-03-04 | $736.00 derived: sum of 3 quarters · filed 2020-03-04 | $1.04K 10-K · filed 2020-03-04 |
| 2018-09-30 | $304.00 10-Q · filed 2019-11-07 | $608.00 derived: sum of 2 quarters · filed 2019-11-07 | $912.00 10-Q · filed 2019-11-07 | $1.22K derived: sum of 4 quarters · filed 2019-11-07 |
| 2018-06-30 | $304.00 10-Q · filed 2019-08-08 | $608.00 10-Q · filed 2019-08-08 | $911.00 derived: sum of 3 quarters · filed 2019-08-08 | $1.22K derived: sum of 4 quarters · filed 2019-08-08 |
| 2018-03-31 | $304.00 10-Q · filed 2019-05-08 | $607.00 derived: sum of 2 quarters · filed 2019-05-08 | $911.00 derived: sum of 3 quarters · filed 2019-05-08 | $1.22K derived: sum of 4 quarters · filed 2019-05-08 |
| 2017-12-31 | $303.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $607.00 derived: sum of 2 quarters · filed 2019-03-01 | $912.00 derived: sum of 3 quarters · filed 2019-03-01 | $1.22K 10-K · filed 2019-03-01 |
| 2017-09-30 | $304.00 10-Q · filed 2018-11-13 | $609.00 derived: sum of 2 quarters · filed 2018-11-13 | $912.00 10-Q · filed 2018-11-13 | $1.19K derived: sum of 4 quarters · filed 2018-11-13 |
| 2017-06-30 | $305.00 10-Q · filed 2018-08-03 | $608.00 10-Q · filed 2018-08-03 | $883.00 derived: sum of 3 quarters · filed 2018-08-03 | $883.00 derived: sum of 4 quarters · filed 2018-08-03 |
| 2017-03-31 | $303.00 10-Q · filed 2018-05-11 | $578.00 derived: sum of 2 quarters · filed 2018-05-11 | $578.00 derived: sum of 3 quarters · filed 2018-05-11 | $578.00 derived: sum of 4 quarters · filed 2018-05-11 |
| 2016-12-31 | $275.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-02 | $275.00 derived: sum of 2 quarters · filed 2018-03-02 | $275.00 derived: sum of 3 quarters · filed 2018-03-02 | $275.00 10-K · filed 2018-03-02 |
| 2016-09-30 | $0.00 10-Q · filed 2017-11-14 | $0.00 derived: sum of 2 quarters · filed 2017-11-14 | $0.00 10-Q · filed 2017-11-14 | $14.35K derived: sum of 4 quarters · filed 2017-11-14 |
| 2016-06-30 | $0.00 10-Q · filed 2017-08-04 | $0.00 10-Q · filed 2017-08-04 | $14.35K derived: sum of 3 quarters · filed 2017-08-04 | $14.35K derived: sum of 4 quarters · filed 2017-08-04 |
| 2016-03-31 | $0.00 10-Q · filed 2017-05-05 | $14.35K derived: sum of 2 quarters · filed 2017-05-05 | $14.35K derived: sum of 3 quarters · filed 2017-05-05 | $14.35K derived: sum of 4 quarters · filed 2017-05-05 |
| 2015-12-31 | $14.35K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $14.35K derived: sum of 2 quarters · filed 2017-02-23 | $14.35K derived: sum of 3 quarters · filed 2017-02-23 | $1.93M 10-K · filed 2017-02-23 |
| 2015-09-30 | $0.00 10-Q · filed 2016-11-01 | $0.00 derived: sum of 2 quarters · filed 2016-11-01 | $1.92M 10-Q · filed 2016-11-01 | $2.10M derived: sum of 4 quarters · filed 2016-11-01 |
| 2015-06-30 | $0.00 10-Q · filed 2016-08-10 | $1.92M 10-Q · filed 2016-08-10 | $2.10M derived: sum of 3 quarters · filed 2016-08-10 | $2.27M derived: sum of 4 quarters · filed 2016-08-10 |
| 2015-03-31 | $1.92M 10-Q · filed 2016-05-13 | $2.10M derived: sum of 2 quarters · filed 2016-05-13 | $2.27M derived: sum of 3 quarters · filed 2016-05-13 | $2.33M derived: sum of 4 quarters · filed 2016-05-13 |
| 2014-12-31 | $177.68K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $347.51K derived: sum of 2 quarters · filed 2016-03-30 | $409.67K derived: sum of 3 quarters · filed 2016-03-30 | $441.72K 10-K · filed 2016-03-30 |
| 2014-09-30 | $169.83K 10-Q · filed 2015-11-12 | $231.99K derived: sum of 2 quarters · filed 2015-11-12 | $264.04K 10-Q · filed 2015-11-12 | |
| 2014-06-30 | $62.15K 10-Q · filed 2015-08-12 | $94.21K 10-Q · filed 2015-08-12 | ||
| 2014-03-31 | $32.05K 10-Q · filed 2015-05-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |